176 related articles for article (PubMed ID: 37498789)
1. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
[TBL] [Abstract][Full Text] [Related]
2. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.
Zhao RR; Wu JH; Tong LW; Li JY; Lu YS; Shao JW
J Colloid Interface Sci; 2024 Apr; 660():257-276. PubMed ID: 38244494
[TBL] [Abstract][Full Text] [Related]
4. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
5. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
6. Triple Tumor Microenvironment-Responsive Ferroptosis Pathways Induced by Manganese-Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics.
He H; Du L; Xue H; An Y; Zeng K; Huang H; He Y; Zhang C; Wu J; Shuai X
Small Methods; 2023 Jul; 7(7):e2300230. PubMed ID: 37096886
[TBL] [Abstract][Full Text] [Related]
7. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798
[TBL] [Abstract][Full Text] [Related]
10. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
11. Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy.
Xie L; Li J; Wang G; Sang W; Xu M; Li W; Yan J; Li B; Zhang Z; Zhao Q; Yuan Z; Fan Q; Dai Y
J Am Chem Soc; 2022 Jan; 144(2):787-797. PubMed ID: 34985903
[TBL] [Abstract][Full Text] [Related]
12. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
13. pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors.
Sun R; Ma W; Ling M; Tang C; Zhong M; Dai J; Zhu M; Cai X; Li G; Xu Q; Tang L; Yu Z; Peng Z
J Control Release; 2022 Oct; 350():525-537. PubMed ID: 36055597
[TBL] [Abstract][Full Text] [Related]
14. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors.
Tao Q; Liu N; Wu J; Chen J; Chen X; Peng C
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471712
[TBL] [Abstract][Full Text] [Related]
15. NIR-responsive copper nanoliposome composites for cascaded ferrotherapy via ferroptosis actived ICD and IFN-γ released.
Wang J; Zhang W; Xie Z; Wang X; Sun J; Ran F; Jiang W; Liu Y; Wang Z; Ran H; Guo D
Biomaterials; 2024 Jul; 308():122570. PubMed ID: 38636133
[TBL] [Abstract][Full Text] [Related]
16. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
17. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
18. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
19. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
20. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
Adv Healthc Mater; 2024 Feb; ():e2303568. PubMed ID: 38319010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]